Did your financial adviser recommend you purchase Valeant stock? If so, those losses might be recoverable through the Financial Industry Regulatory Authority (FINRA) arbitration claims process. Brokerage firms have a duty to perform basic due diligence on investments before they are recommended to clients. Valeant Pharmaceuticals International Inc. is a drugmaker whose stock has tumbled about 70% this year amid questions about its accounting and business practices. If you were sold stock in Valeant, you may be able to bring a claim against the investment adviser and company who sold it to you. The investment may have been unsuitable and brokerage firms can be held liable for unsuitable investments. We sue brokerage firms in the arbitration process on a contingency fee basis.
Disclaimer
The posting on this site are mere OPINIONS and NOT statements of fact in any way whatsoever. The information should not be relied upon and there have been no findings made against the firms or individuals referenced on this site. In addition, this Blog is made available for educational purposes only and incorporates information from the web as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this blog site you understand that there is no attorney client relationship between you and Stoltmann Law Offices (161 N Clark Street 16th Floor Chicago, IL 60601). The Blog opinions should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.
PLEASE NOTE THIS IS ADVERTISING AND IT IS NOT A NEWSPAPER ARTICLE OR POST FROM AN INDEPENDENT OR NON-BIASED, NEWS SITE, NEWS SOURCE OR NEWSPAPER.
